Cargando…

Targeting SARS-CoV-2 Non-Structural Proteins

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped respiratory β coronavirus that causes coronavirus disease (COVID-19), leading to a deadly pandemic that has claimed millions of lives worldwide. Like other coronaviruses, the SARS-CoV-2 genome also codes for non-structural...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tam, Donald, Lorenzo-Leal, Ana C., Hernández, Luis Ricardo, Bach, Horacio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455537/ https://www.ncbi.nlm.nih.gov/pubmed/37629182 http://dx.doi.org/10.3390/ijms241613002

Ejemplares similares

Adherence of SARS-CoV-2 Delta variant to a surgical mask and N95 respirators
por: Lorenzo-Leal, Ana C, et al.
Publicado: (2022)

Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An in silico study
por: Chaudhuri, Ankur
Publicado: (2021)

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19
por: Yadav, Rohitash, et al.
Publicado: (2021)

Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins
por: Gorkhali, Ritesh, et al.
Publicado: (2021)

Is SARS-CoV-2 Vertically Transmitted?
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2020)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021)

Characterization of Structural and Energetic Differences between Conformations of the SARS-CoV-2 Spike Protein
por: Moreira, Rodrigo A., et al.
Publicado: (2020)

Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing
por: Raj, Resal
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
por: Trigueiro-Louro, João, et al.
Publicado: (2020)

A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites
por: Jahirul Islam, Md., et al.
Publicado: (2023)

Viroporin Activity of SARS-CoV E Protein
por: Liao, Ying, et al.
Publicado: (2006)

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
por: Gavor, Edem, et al.
Publicado: (2020)

Novel Mutations in the Non-Structure Protein 2 of SARS-CoV-2
por: Nakhaie, Mohsen, et al.
Publicado: (2023)

Secondary Structures of MERS-CoV, SARS-CoV, and SARS-CoV-2 Spike Proteins Revealed by Infrared Vibrational Spectroscopy
por: D’Arco, Annalisa, et al.
Publicado: (2023)

SARS-CoV-2-Therapie schützt auch Geimpfte
por: Bach, Bianca
Publicado: (2022)

Subcellular Localization of SARS-CoV Structural Proteins
por: Lopez, Lisa A., et al.
Publicado: (2006)

The Structural Characterization and Antigenicity of the S Protein of SARS-CoV
por: Li, Jingxiang, et al.
Publicado: (2003)

Structural insights into SARS-CoV-2 proteins
por: Arya, Rimanshee, et al.
Publicado: (2021)

Structure of SARS-CoV-2 spike protein
por: Zhang, Jun, et al.
Publicado: (2021)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
por: Hatmal, Ma’mon M., et al.
Publicado: (2020)

Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9
por: Littler, Dene R., et al.
Publicado: (2020)

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
por: Sternberg, Ariane, et al.
Publicado: (2020)

Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2
por: García-Gutiérrez, Ponciano, et al.
Publicado: (2021)

Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
por: Calvaresi, Valeria, et al.
Publicado: (2023)

The natural thermal sensitivity of SARS-CoV-2
por: Stewart, Patrick D Shaw, et al.
Publicado: (2022)

SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
por: Low, Zheng Yao, et al.
Publicado: (2022)

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
por: Bhardwaj, Taniya, et al.
Publicado: (2023)

Antimicrobial Activity of Filtered Far-UVC Light (222 nm) against Different Pathogens
por: Lorenzo-Leal, Ana C., et al.
Publicado: (2023)

Impfung gegen Influenza, Hygiene gegen SARS-CoV-2
por: Bach, Bianca
Publicado: (2020)

Crystal structure of the CoV-Y domain of SARS-CoV-2 nonstructural protein 3
por: Li, Yunfeng, et al.
Publicado: (2023)

Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2
por: Solanki, Vandana, et al.
Publicado: (2021)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

T Lymphocytes as Targets for SARS-CoV-2
por: Kuklina, Elena M.
Publicado: (2022)

High-specificity targets in SARS-CoV-2 N protein for serological detection and distinction from SARS-CoV
por: Yu, Jianhai, et al.
Publicado: (2022)

Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2
por: Wrobel, Antoni G., et al.
Publicado: (2021)

Performance of Elecsys Anti-SARS CoV-2 (Roche) and VIDAS Anti-SARS CoV-2 (Biomérieux) for SARS-CoV-2 Nucleocapsid and Spike Protein Antibody Detection
por: Inés, Riberi María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_24obcs9ph32dnnr2bk6tes6q0o